Table 7.
Castrate (n = 8) |
Low T/E (n = 7) |
Normal T/E (n = 8) |
Normal T/Low E (n = 8) |
||||||
---|---|---|---|---|---|---|---|---|---|
Baseline | Week 4 | Baseline | Week 4 | Baseline | Week 4 | Baseline | Week 4 | P value (Overall RM-ANOVA) | |
Estrone, pg/ml | 360 (169) | 179 (108) | 393 (180) | 383 (131) | 562 (574) | 467 (347) | 329 (114) | 155 (135) | 0.15 |
17β-Estradiol, pg/ml | 849 (471) | 457 (310) | 1,116 (605) | 600 (387) | 810 (288) | 492 (229) | 690 (208) | 548 (393) | 0.70 |
Data are shown as means (SD). Baseline and end-of-treatment adipose tissue estrogen levels. P values represent time-by-group interactions from RM-ANOVA comparing all treatment arms at baseline and week 4.